Mawer Investment Management’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-61,966	Closed	-$25.4M	–	113
2022 Q1	$25.4M	Sell	61,966 -16,073	-21%	-$6.29M	0.12%	78
2021 Q4	$36.6M	Sell	78,039 -16,753	-18%	-$7.21M	0.16%	78
2021 Q3	$40.2M	Sell	94,792 -23	-0%	-$9.7K	0.19%	78
2021 Q2	$34M	Sell	94,815 -38,772	-29%	-$12.8M	0.17%	79
2021 Q1	$37.6M	Buy	133,587 +252	+0.2%	+$72.1K	0.2%	76
2020 Q4	$37.8M	Sell	133,335 -289	-0.2%	-$81.1K	0.22%	73
2020 Q3	$36.7M	Sell	133,624 -24,885	-16%	-$6.59M	0.24%	67
2020 Q2	$36M	Sell	158,509 -23,023	-13%	-$4.52M	0.27%	60
2020 Q1	$27.6M	Sell	181,532 -27,110	-13%	-$4.17M	0.25%	62
2019 Q4	$31.4M	Sell	208,642 -16,116	-7%	-$2.35M	0.25%	61
2019 Q3	$31.9M	Sell	224,758 -71,667	-24%	-$9.87M	0.29%	59
2019 Q2	$37.1M	Buy	296,425 +6,200	+2%	+$732K	0.24%	74
2019 Q1	$32M	Sell	290,225 -140	-0%	-$14.6K	0.23%	69
2018 Q4	$28.5M	Sell	290,365 -23,435	-7%	-$2.54M	0.24%	71
2018 Q3	$38.7M	Buy	313,800 +900	+0.3%	+$101K	0.29%	68
2018 Q2	$31.1M	Buy	312,900 +39,094	+14%	+$3.6M	0.25%	73
2018 Q1	$24.2M	Buy	273,806 +247,541	+942%	+$23.2M	0.2%	77
2017 Q4	$2.59M	Sell	26,265 -20	-0.1%	-$1.96K	0.02%	108
2017 Q3	$2.53M	Buy	+26,285	New	+$2.38M	0.02%	104